| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799 [L. A. P., J. M. H.] and Cell Culture Laboratory, Children's Hospital of Michigan, and Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan 48201-9985 [B. H.]
3 To whom requests for reprints should be addressed, at Department of Pharmacology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814-4799.
The sensitivity of the human glucocorticoid receptor (hGR) gene to mutagenesis by the cancer chemotherapeutic drugs adriamycin, bleomycin, and chlorambucil was evaluated using glucocorticoid-sensitive (dexs) subclones of the human leukemic cell line CEM-C7. Treatment of cells with either bleomycin or chlorambucil increased the frequency of glucocorticoid-resistant (dexr) clones 3.3- and 10-fold, respectively. Measurement of steroid-binding activity in intact dexr cells demonstrated that the predominant phenotype of drug-induced dexr clones was receptorless (r–). dexs CEM cells express only one functional hGR allele and, in addition, are heterozygous for a BclI restriction fragment length polymorphism in the hGR gene (L. A. Palmer and J. M. Harmon, Cancer Res., 51:5224–5231, 1991). To determine the basis of the r- phenotype, BclI digests of genomic DNA isolated from r+ and r– cell lines were examined for the presence of the polymorphic 2.4- and 4.4-kilobase digestion products. A deletion of all or part of the hGR gene was demonstrated by the absence of the 4.4-kilobase fragment in one of two bleomycin-induced dexr clones, as well as the ICR191-induced dexr cell line ICR27TK.3. Cytogenetic analysis of ICR27TK.3 showed that the distal portion of the long arm of one chromosome 5 had been replaced with a portion of chromosome 15. Thus, in at least two dexr cell lines, deletions and/or chromosome breaks in the hGR locus appear to account for the r- phenotype.
1 This investigation was supported by USPHS Grant CA32226 awarded by the National Cancer Institute. Cytogenetic analysis was carried out under National Cancer Institute contract N01-CP-85645 to Children's Hospital of Michigan, Detroit, MI 48201. The opinions or assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense or the Uniformed Services University of the Health Sciences.
2 Present address: Experimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 5/12/92. Accepted 9/23/92.
This article has been cited by other articles:
![]() |
J. A.E. Irving, L. Minto, S. Bailey, and A. G. Hall Loss of Heterozygosity and Somatic Mutations of the Glucocorticoid Receptor Gene Are Rarely Found at Relapse in Pediatric Acute Lymphoblastic Leukemia but May Occur in a Subpopulation Early in the Disease Course Cancer Res., November 1, 2005; 65(21): 9712 - 9718. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Hillmann, J. Ramdas, K. Multanen, M. R. Norman, and J. M. Harmon Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo Cancer Res., April 1, 2000; 60(7): 2056 - 2062. [Abstract] [Full Text] |
||||
![]() |
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension Hypertension, December 1, 1999; 34(6): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. BJORNTORP and R. ROSMOND Hypothalamic Origin of the Metabolic Syndrome X Ann. N.Y. Acad. Sci., November 18, 1999; 892(1): 297 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ramdas, W. Liu, and J. M. Harmon Glucocorticoid-induced Cell Death Requires Autoinduction of Glucocorticoid Receptor Expression in Human Leukemic T Cells Cancer Res., March 1, 1999; 59(6): 1378 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, G. Srinivasan, and E. B. Thompson Protein-Protein Interactions Are Implied in Glucocorticoid Receptor Mutant 465*-mediated Cell Death J. Biol. Chem., October 10, 1997; 272(41): 25873 - 25880. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |